News | April 16, 2024
Moderna pauses plan to build mRNA manufacturing facility in Kenya
The demand in Africa for COVID-19 vaccines has declined
The demand in Africa for COVID-19 vaccines has declined
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
The initial consideration for the transaction is US$ 12 million
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Subscribe To Our Newsletter & Stay Updated
